ADA: DPP4 inhibitors and cardiovascular outcomes: connecting the dotsJune 18, 2015DiabetesCardiologyEndocrinology
‘Modest’ uptake of novel anticoagulants in real-world practiceJune 9, 2015CardiologyHematologyThrombosis
ELIXA trial: No cardiovascular risk with GLP-1 receptor agonist lixisenatideJune 9, 2015DiabetesCardiologyEndocrinology
FDA panel set to review two biologic lipid-lowering drugs for approvalJune 8, 2015CardiologyEndocrinology
IHC: IV dihydroergotamine linked to increased thrombosis riskJune 7, 2015ThrombosisNeurologyHematologyCardiology
Tight glycemic control: Somewhat fewer CV events, same mortalityJune 3, 2015DiabetesCardiologyEndocrinology
Newborn’s pulmonary hypertension risk up slightly after SSRI exposure in pregnancyJune 2, 2015CardiologyPediatricsMental Health
